Not recruiting
Acute lymphocytic leukaemia
Not recruitingStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
Registered drugNo placebo
Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
Registered drugNo placebo
- Disease:Acute lymphocytic leukaemia
- Substances:BlinatumomabBortezomib+16
Countries:
Austria
Austria- Participants:0–17 years
- Substances:Blinatumomab



